blackjack3d / iStockphoto.com
Biotechnology company United Therapeutics has reached a settlement with Actavis Laboratories to resolve a dispute over patents concerning a blood pressure drug.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
United Therapeutics, Actavis Laboratories, Orenitram, trepostinil, blood pressure drugs, Orphan Drug Act, orphan drug developer, rare disease patent,